Washington University School of Medicine, Saint Louis, MO; M.D., Ph.D. in Molecular Cell Biology, 2006
Seattle Children’s Hospital/University of Washington School of Medicine, Department of Pediatrics, Seattle, WA; Pediatrics Internship, 2006-2007; Pediatrics Residency, 2007-2009
Seattle Children’s Hospital/University of Washington School of Medicine/Fred Hutchinson Cancer Research Center, Department of Pediatrics, Division of Hematology/Oncology, Seattle, WA; Pediatric Hematology/Oncology Fellowship, 2009-2012
Fred Hutchinson Cancer Research Center, Clinical Research Division, Seattle, WA; Research Associate, 2012-2018
U. of Washington School of Medicine, Department of Pediatrics, Division of Hematology/Oncology; Acting Instructor, 2012-2016
U. of Washington School of Medicine, Department of Pediatrics, Division of Hematology/Oncology; Acting Assistant Professor, 2016-2018
Dr. Hadland’s research is focused on understanding the factors that control the formation of the “hematopoietic” stem cells that give rise to blood and immune cells. He is harnessing new technologies to simultaneously analyze gene activities across the many different cell types within the special “hematopoietic stem cell niche,” the physical site within which the stem cells evolve, and to characterize interactions between the various cells. He aims to identify the specific biological signals that trigger the formation of blood stem cells. His ultimate goal is to use new findings to develop a system for generating and cultivating blood stem cells in the lab, providing an invaluable resource for research and enabling studies of novel treatments to cure diseases including hematologic cancers and inherited blood and immune disorders.
Specific research foci include:
Role of Notch and other signal pathways in embryonic hematopoietic stem cell development,
Analysis of the hematopoietic niche during hematopoietic stem cell emergence, using single cell functional and molecular techniques,
Laboratory platforms for engineering hematopoietic stem and progenitor cell development,
Directed differentiation of murine and human pluripotent stem cells (that can make many different cell types) to selectively hematopoietic stem and progenitor cells, and
Development of certain (“innate-like”) immune cells during embryonic hematopoiesis
Dr. Hadland is a hematologist/oncologist and stem cell transplantation expert who treats young patients in the Seattle Children’s Hospital transplant service.
Fred Hutch is proud to be an Equal Opportunity and VEVRAA Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability, marital or veteran status, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. Read the EEO is the Law poster here.